Ipca Laboratories Limited
IPCALAB
Ранг среди акций
#3414
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures... Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Цена акции
$20.02
Последняя синхронизация: 2026-10-19
Рыночная капитализация
$5.08B
Изменение (1 день)
-1.65%
Изменение (1 год)
38.46%
Страна
IN
Торговля Ipca Laboratories Limited (IPCALAB)
Категория
Healthcare
Коэффициент P/B для Ipca Laboratories Limited (IPCALAB)
Коэффициент P/B на October 2026 TTM: 6.01
Согласно последним финансовым отчетам и цене акций Ipca Laboratories Limited, текущий коэффициент P/B (TTM) составляет 6.01. В конце 2024 он составлял 4.97.
История P/B для Ipca Laboratories Limited с 2005 по 2026
Коэффициент P/B в конце каждого года
| Год | P/B | Изменить |
|---|---|---|
| 2026 (TTM) | 6.01 | 18.32% |
| 2025 | 5.08 | 2.13% |
| 2024 | 4.97 | 41.30% |
| 2023 | 3.52 | -28.52% |
| 2022 | 4.92 | -3.99% |
| 2021 | 5.13 | 5.76% |
| 2020 | 4.85 | 23.20% |
| 2019 | 3.94 | 26.08% |
| 2018 | 3.12 | -2.65% |
| 2017 | 3.21 | -1.40% |
| 2016 | 3.25 | -10.50% |
| 2015 | 3.63 | -33.22% |
| 2014 | 5.44 | 27.37% |
| 2013 | 4.27 | 26.78% |
| 2012 | 3.37 | -6.01% |
| 2011 | 3.58 | -7.79% |
| 2010 | 3.89 | 195.76% |
| 2009 | 1.31 | -49.85% |
| 2008 | 2.62 | -17.46% |
| 2007 | 3.18 | 34.15% |
| 2006 | 2.37 | 2.83% |
| 2005 | 2.30 | 0.00% |
Коэффициент P/B для аналогичных компаний или конкурентов
| Компания | P/B | Разница P/B | Страна |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -16.13% |
IN
|
